Cancer Family
Childhood Malignant Neoplasm
CI-CAN-00000132Explore in graph →
Pediatric263 active trials1 approved drugs46 evidence items
- NCIt
- C4005
Loading cancer entity…
Cancer Family
CI-CAN-00000132Explore in graph →
Clinical trials
1,178 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (92)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07278414 | Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer | recruiting | — | 60 | Wake Forest University Health SciencesOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT02315599 | Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials | enrolling by invitation | — | 500 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2026 |
| clinicaltrials |
| NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | active not recruiting | Phase 3 | 560 | Dana-Farber Cancer InstituteOTHER | 2 | Jul 16, 2026 | clinicaltrials |
| NCT06102330 | Multicenter HomeVENT: Home Values and Experiences Navigation Track(HomeVENT) | recruiting | N/A | 600 | Johns Hopkins UniversityOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT06747910 | Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma | recruiting | N/A | 188 | St. Jude Children's Research HospitalOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT03843528 | Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation | active not recruiting | Phase 1 | 15 | Johns Hopkins All Children's HospitalOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT04284774 | Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial | active not recruiting | Phase 2 | 5 | National Cancer Institute (NCI)NIH | 2 | Jul 15, 2026 | clinicaltrials |
| NCT06942039 | Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation | recruiting | Early Phase 1 | 15 | C17 CouncilOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT02813135 | European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors(ESMART) | recruiting | Phase 1 / Phase 2 | 472 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 6 | Jul 10, 2026 | clinicaltrials |
| NCT03810196 | CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT | recruiting | N/A | 50 | Children's Hospital of PhiladelphiaOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06050850 | Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL(NOURISH-ALL) | not yet recruiting | N/A | 20 | University of Kansas Medical CenterOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03208387 | Understanding the Late Effects of Surviving a Pediatric Brain Tumor | active not recruiting | — | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT06739447 | Hospital Based Continuous Patient Monitoring System | not yet recruiting | N/A | 250 | University of Alabama at BirminghamOTHER | 0 | Jul 2, 2026 | clinicaltrials |
| NCT02094794 | Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML | active not recruiting | Phase 2 | 108 | City of Hope Medical CenterOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT04416568 | Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers | active not recruiting | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT03241940 | Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies | active not recruiting | Phase 1 | 33 | Stanford UniversityOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT07675967 | Clonal Hematopoiesis Chemotherapy and Radiation Effects Study(CH CARE) | recruiting | — | 5,000 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT03297034 | Swiss Childhood Cancer Survivor Study(SCCSS) | recruiting | — | 4,136 | University of BernOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT03571321 | Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia | recruiting | Phase 1 | 15 | University of ChicagoOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | recruiting | Early Phase 1 | 15 | Nationwide Children's HospitalOTHER | 6 | Jun 29, 2026 | clinicaltrials |
| NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | recruiting | Phase 2 | 300 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06411704 | Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer | active not recruiting | — | 10 | St. Jude Children's Research HospitalOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07419490 | Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy(UOT WPXRT) | recruiting | N/A | 26 | University of South FloridaOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07656740 | Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers(NOMIC) | not yet recruiting | — | 50 | Peking University Cancer Hospital & InstituteOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT00684580 | Protocol For Collecting Data On Patients With Childhood Cancer | recruiting | — | 30,000 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04024761 | A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation | recruiting | Phase 1 | 50 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04125095 | Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images | active not recruiting | — | 367 | St. Jude Children's Research HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06193759 | Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)(IMPACT) | recruiting | Phase 1 | 12 | Children's National Research InstituteOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06636435 | A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer | recruiting | Phase 1 | 66 | Chiome Bioscience Inc.INDUSTRY | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05582551 | Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors | recruiting | N/A | 146 | Washington University School of MedicineOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT05384288 | Response to Influenza Vaccination in Pediatric Oncology Patients | recruiting | — | 150 | St. Jude Children's Research HospitalOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07019259 | Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors | recruiting | N/A | 20 | Yale UniversityOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT05754840 | CANnabinoids in Pediatric ONCology(CAN-PONC) | recruiting | Phase 1 / Phase 2 | 60 | University of ManitobaOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT05425043 | Granulocyte Transfusions After Umbilical Cord Blood Transplant | active not recruiting | N/A | 40 | University of ManchesterOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT01518400 | LIFE Cancer Survivorship Database for Pediatric Cancer | recruiting | — | 5,000 | Children's Hospital Los AngelesOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05800210 | Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases | recruiting | Phase 2 | 20 | University of FloridaOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT05120518 | Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells | recruiting | — | 150 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT06055296 | Multisite Implementation of COMPRENDO(COMPRENDO) | recruiting | N/A | 450 | University of California, San DiegoOTHER | 1 | Jun 3, 2026 | clinicaltrials |
| NCT05146739 | Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory That Expresses E-selectin Ligand on the Cell Membrane | active not recruiting | Phase 1 | 8 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2026 | clinicaltrials |
| NCT03157323 | Low GI Diet in Children and Adolescents With ALL | active not recruiting | N/A | 88 | Columbia UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT03790943 | Cardiac Dysfunction in Childhood Cancer Survivors(Cardio-Onco) | recruiting | — | 500 | University of BernOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04934293 | Virtual Reality for Children in Radiotherapy (REVER)(REVER) | recruiting | N/A | 47 | Centre Antoine LacassagneOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT05418088 | Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies | recruiting | Phase 1 | 54 | Sumithira VasuOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07606170 | The Impact of Fatigue on Quality of Life and Activities of Daily Living in Pediatric Oncology Patients | enrolling by invitation | — | 89 | Medipol UniversityOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT03180827 | Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment | active not recruiting | N/A | 100 | Gumy-Pause FabienneOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT03180918 | Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment | recruiting | N/A | 100 | Gumy-Pause FabienneOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT05958316 | Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer | recruiting | N/A | 126 | Virginia Commonwealth UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07462143 | A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer | recruiting | Phase 2 / Phase 3 | 80 | RemeGen Co., Ltd.INDUSTRY | 1 | May 22, 2026 | clinicaltrials |
| NCT06230016 | Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program(APADHOP) | active not recruiting | — | 38 | University Hospital, GrenobleOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07481357 | A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma | recruiting | Phase 1 | 51 | Dong-A ST Co., Ltd.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jul 17, 2026source: clinicaltrials